Total Funding
25
45
Total FundingSeries B raised
Growth Score 25 in past quarter
1 pts
Heat Score 45 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
172618
Rain Oncology is a operator of a clinical stage biotechnology company.
- Ranga Yarlagadda: Director of Corporate DevelopmentPast Role: BeanGenius, Co-Founder
- Dharmendra Singh: Senior ScientistPast Role: Nivien Therapeutics, Scientist, Cancer Biology
Pathos
About the Company
Rain Oncology Inc. is a precision oncology company developing therapies that target oncogenic drivers to genetically select patients it believes will most likely benefit.